Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Impact de caractéristiques cytogénétiques défavorables spécifiques sur les résultats après allogreffe de cellules hématopoïétiques dans le syndrome myélodysplasique avec cytogénétique de très mauvais pronostic : une étude du Chronic Malignancies Working Party de l'EBMT

Études rétrospectives

Syndrome Myélodysplasique (MDS) ou MDS/MPN

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Prevention and management of conditioning related skin toxicity in paediatric HSCT patients

Closed Survey/Study

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Mihaela Hartmann, Hilda Mekelenkamp

Prévention et gestion de la toxicité cutanée liée à la préparation chez les patients pédiatriques en greffe de cellules souches hématopoïétiques (HSCT)

Toutes les maladies

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Mihaela Hartmann, Hilda Mekelenkamp

Machine Learning grading system for acute graft-versus host disease

Retrospective Studies

Complications Working Party (CWP)

Type of treatment

Principal investigator

Steroid refractory acute graft-versus-host disease - survey

Complications Working Party (CWP)

Type of treatment

Principal investigator

Renal failure in aplastic anemia

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

Beatrice Drexler

Outcomes of treatment with anti thymocyte globulin (ATG) for acquired pure red cell aplasia

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

RACE-2: long-term follow-up of patients participating in RACE: the prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for Severe Aplastic Anemia patients

Non-interventional Prospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Immunosuppressive Treatment (IST)

Principal investigator

Régis Peffault de Latour, Antonio M. Risitano

Intrabone infusion of a single umbilical cord blood unit in adults with hematological disease: a Eurocord, CTIWP-EBMT Analysis

Retrospective Studies

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Jacopo Peccatori

Incidence and outcome of CMV and EBV reactivations after autologous HSCT for autoimmune diseases: a retrospective survey from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Tobias Alexander

Comparison of Cyclophosphamide/ATG vs BEAM/ATG conditioning regimens in autologous HSCT for Multiple Sclerosis

Retrospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Riccardo Saccardi

Observational Study in Multiple Sclerosis patients treated with autologous hematopoietic stem cell Transplantation (OMST)

Non-interventional Prospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Riccardo Saccardi